CDT - CONDUIT PHARMACEUTICALS INC.
0.67
0.003 0.433%
Share volume: 35,006
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$0.67
0.00
0.00%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 03-28-2025 | 05-14-2025 | 11-13-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | |
| nan% | ||||
| Operating expenses | 3.513 M | 4.009 M | 7.033 M | |
| Selling general and admin | 3.381 M | 2.700 M | 5.501 M | |
| Research and development | 132.000 K | 1.309 M | 1.532 M | |
| Total expenses | 3.513 M | 4.009 M | 7.033 M | |
| 14.12% | 75.43% | |||
| Operating income | -3.513 M | -4.009 M | -7.033 M | |
| Ebit | -1.449 M | -4.978 M | -7.077 M | |
| Pretax income | -2.406 M | -5.146 M | -7.118 M | |
| 113.88% | 38.32% | |||
| Income tax | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -2.406 M | -5.146 M | -7.118 M | |
| -113.88% | -38.32% |